Dariusz Korczyk

A better understanding of the mechanisms and pathophysiological pathways of heart failure (HF), improved management of associated comorbidities, and advances in identifying genetic cardiac disease have led to a near-revolution in the management of patients in terms of pharmacological treatments, surgery and devices. These developments have transformed outcomes and HF-associated mortality, and gene therapies further promise a brighter future for patients...